Medical research centre planned for East Yorkshire

Yorkshire-based property developer Wykeland Group has secured an £80M-plus investment by global medical technology business Smith+Nephew to build a medical research, development and manufacturing facility at the Melton West business park in East Yorkshire.

Located eight miles from Smith+Nephew’s current site in Hull, Wykeland said the investment will create a world-class R&D, manufacturing and flexible office environment, which is expected to support more than £8bn of sales in its first 10 years of operation.

Dominic Gibbons, Managing Director at Wykeland, and owner and developer of Melton West, said: “We are delighted the strategic, long-term investments we have made in the infrastructure at Melton West have enabled Smith+Nephew to stay within the region and make such a large investment in a state-of-the-art new facility.”

The 200-acre Melton West business park is said to be one of Yorkshire and the Humber’s premier locations for investment and job creation. It is located west of Hull, off the A63, with easy access to the M62.